Enzymatically Hydrolyzed Rice Bran Alleviates Bone Loss in Aging Mice via the Gut-Bone Axis
نخالة الأرز المتحللة إنزيمياً تخفف فقدان العظام لدى الفئران المسنة عبر محور الأمعاء والعظام
Journal: Food & function
University: Research Institution
Study Type: animal
Evidence Level: preliminary
Published:
⚠️ Warning: This is a preliminary study (animal/cell) and has not been proven in humans.
30-Second Summary
This animal study investigated the effects of enzymatically hydrolyzed steam-exploded rice bran (ESRB) on bone and behavioral alterations in a D-galactose-induced aging mouse model. Supplementation with ESRB alleviated bone loss and gut microbial dysbiosis in a dose-dependent manner.
1-Minute Summary
This study evaluated the potential of enzymatically hydrolyzed steam-exploded rice bran (ESRB) to mitigate skeletal and behavioral deterioration in D-galactose-induced aging mice. Administration of ESRB improved locomotor activity, enhanced bone mineral density, and preserved bone microarchitecture. Furthermore, the supplementation favorably modulated gut microbial composition, suggesting a gut-bone axis mechanism. These findings highlight the potential of specific dietary fiber interventions in managing age-related bone metabolic decline.
3-Minute Summary
The investigated study explores the intersection of nutritional science, gerontology, and gastroenterology by evaluating the impact of enzymatically hydrolyzed steam-exploded rice bran (ESRB) on bone loss and behavioral alterations in a murine model of D-galactose-induced aging. Aging is universally associated with progressive skeletal deterioration, commonly manifesting as osteoporosis, alongside cognitive decline and shifts in the composition of the gastrointestinal microbiota. While dietary interventions offer a promising, low-toxicity approach to mitigating these age-related pathologies, native agricultural byproducts like raw rice bran often exhibit poor bioavailability and limited solubility due to rigid plant cell wall matrices. To overcome this, the researchers utilized a combination of steam explosion—a physical pretreatment breaking down lignocellulosic structures—and subsequent enzymatic hydrolysis to maximize the release of bioactive compounds, soluble dietary fibers, and phenolic constituents. In the experimental design, mice were subjected to D-galactose injections to artificially accelerate aging, inducing systemic oxidative stress, gut microbial dysbiosis, and marked deterioration of trabecular bone microarchitecture. Supplementation with ESRB demonstrated a pronounced, dose-dependent amelioration of these pathological phenotypes. Behaviorally, ESRB-treated subjects exhibited improved locomotor activity, enhanced cognitive performance, and superior motor coordination compared to the untreated aging control group. Skeletally, micro-computed tomography (μCT) and biochemical analyses revealed that ESRB supplementation preserved bone mineral density (BMD), increased the bone volume fraction (BV/TV), reduced trabecular separation (Tb·Sp), and elevated systemic markers of bone formation, notably serum bone-specific alkaline phosphatase. Crucially, the mechanistic underpinning of these systemic benefits points directly to the gut-bone axis. D-galactose exposure disrupts intestinal microbial equilibrium, favoring pro-inflammatory taxa and impairing mucosal integrity, which typically exacerbates systemic low-grade inflammation ('inflammaging') and accelerates osteoclastogenesis. Administration of ESRB modulated the intestinal microbiota, reversing dysbiosis and promoting the growth of beneficial, short-chain fatty acid (SCFA)-producing microbes. These microbial changes reinforce intestinal barrier function, attenuate systemic inflammation, and favorably regulate osteoblast-osteoclast coupling. Overall, this study highlights enzymatically modified rice bran as a high-value functional food ingredient capable of leveraging the gut-bone axis to protect against age-related skeletal and neurological decline, laying a robust preclinical foundation for future human nutritional strategies.
Full Analysis
1. Introduction and Background Osteoporosis is a systemic skeletal disorder characterized by compromised bone strength, microarchitectural deterioration of bone tissue, and a consequently heightened risk of fragility fractures. As global populations age, the socioeconomic and clinical burdens of age-related bone loss have surged, prompting intense investigation into preventative and therapeutic dietary strategies. Aging is frequently accompanied by a triad of interconnected pathologies: oxidative stress, chronic low-grade systemic inflammation (often termed 'inflammaging'), and profound shifts in the composition and metabolic activity of the gut microbiota. Recent advances in microbiome research have underscored the critical role of the 'gut-bone axis'—a bidirectional communication network linking intestinal microbial ecology to skeletal homeostasis via immune modulation, endocrine signaling, and nutrient absorption. Rice bran, a major byproduct of the rice milling industry, is exceptionally rich in bioactive constituents, including dietary fibers, ferulic acid, phytosterols, tocopherols, and various polyphenols that possess potent antioxidant and anti-inflammatory properties. However, raw rice bran is structurally rigid due to its complex lignocellulosic cell wall matrix, which hinders the release and gastrointestinal absorption of these beneficial phytochemicals. To address this limitation, the authors of this study evaluated enzymatically hydrolyzed steam-exploded rice bran (ESRB). Steam explosion uses high-pressure steam followed by an instantaneous decompression to disrupt recalcitrant plant cell walls, while subsequent enzymatic hydrolysis breaks down complex polysaccharides into smaller, highly bioavailable oligosaccharides and free phenolic compounds. 2. Methodology and Experimental Design To evaluate the efficacy of ESRB, the investigators employed a well-established murine model of accelerated aging induced by D-galactose (D-gal). Chronic administration of D-gal overloads metabolic pathways, leading to the overproduction of reactive oxygen species (ROS), advanced glycation end-products (AGEs), and systemic oxidative damage that mimics natural senescence. - Animal Model and Grouping: Healthy mice were randomly allocated into control groups and D-gal-induced aging groups. The aging groups were further stratified to receive varying doses of ESRB supplementation alongside D-gal administration over a sustained experimental period. - Behavioral Assessment: Given that D-gal-induced aging also impairs neurological function, the study incorporated comprehensive behavioral batteries, including tests for locomotor activity (open field test), spatial learning and memory, and motor coordination, ensuring a holistic assessment of systemic health benefits. - Skeletal and Densitometric Analysis: Following sacrifice, femurs and tibias were harvested for micro-computed tomography (μCT) scanning to evaluate trabecular bone microarchitecture parameters, including bone mineral density (BMD), bone volume fraction (BV/TV), trabecular number (Tb.N), and trabecular separation (Tb.Sp). - Biochemical and Serological Assays: Blood serum was analyzed for key biomarkers of bone turnover, specifically assessing formation markers such as bone-specific alkaline phosphatase (BALP) and resorption indicators, to ascertain whether ESRB mitigated bone loss by shifting the balance toward osteoblastogenesis. - Microbiome Analysis: 16S rRNA gene sequencing of fecal samples was performed to characterize shifts in gut microbial richness, alpha/beta diversity, and taxonomic abundances, shedding light on how ESRB restructures the intestinal ecosystem. 3. Detailed Results and Mechanisms - Skeletal Protection: D-galactose exposure induced severe osteoporotic phenotypes, characterized by a significant reduction in BMD, diminished BV/TV, and increased trabecular separation. Dietary intervention with ESRB dose-dependently mitigated these deficits. Mice receiving high-dose ESRB exhibited near-normal bone architecture, preserved trabecular networks, and elevated levels of serum bone-specific alkaline phosphatase, indicating enhanced osteoblastic activity. - Amelioration of Behavioral Deficits: Beyond skeletal protection, ESRB administration ameliorated D-gal-induced neurological decline. Treated mice showed marked improvements in exploratory behavior, reduced anxiety-like metrics in open-field settings, and improved motor coordination, hinting at shared systemic pathways (such as reduced oxidative stress and neuroinflammation) influenced by the gut-bone-brain axis. - Gut Microbiota Modulation: Microbiome profiling confirmed that D-gal exposure triggered severe dysbiosis, characterized by a decrease in beneficial taxa and an increase in opportunistic, inflammation-associated pathobionts. ESRB supplementation successfully restored microbial diversity. Specifically, it enriched the populations of short-chain fatty acid (SCFA)-producing bacteria (such as specific genera within Lachnospiraceae and Ruminococcaceae). SCFAs, particularly acetate, propionate, and butyrate, are known to lower intestinal luminal pH, inhibit pathogen colonization, strengthen the epithelial tight junction barrier (reducing lipopolysaccharide translocation), and directly suppress osteoclast differentiation through immunomodulatory mechanisms. 4. Limitations Despite its rigorous design, the study has certain limitations inherent to preclinical murine research: - Species Differences: While mice provide valuable mechanistic insights, murine bone remodeling kinetics and gut microbial profiles differ fundamentally from humans. Clinical translation requires confirmation in human randomized controlled trials. - Mechanistic Gaps: Although microbial shifts and SCFA production are strongly correlated with bone protection, direct causal pathways (e.g., fecal microbiota transplantation experiments or specific receptor knockout models) would further solidify the exact signaling cascades involved. - Compound Characterization: While ESRB's overall efficacy is proven, the specific active constituent (or synergistic combinations thereof) responsible for the primary therapeutic effect remains to be isolated and characterized in high-resolution detail.Health Implications
This preclinical study underscores the therapeutic potential of utilizing modified agricultural byproducts, specifically enzymatically hydrolyzed steam-exploded rice bran, to mitigate age-related bone loss and cognitive decline via the gut-bone axis. For human health, these findings highlight the profound systemic impact of dietary fiber modification and bioactive phytochemicals in combating oxidative stress and low-grade inflammation associated with aging. Incorporating stabilized, bio-processed whole-grain fractions and fiber-rich prebiotics into daily nutritional habits may support gastrointestinal microbial diversity, enhance mineral absorption, and promote long-term skeletal and metabolic resilience.
Key Findings
- ESRB supplementation improved bone mineral density and bone volume fraction in aging mice.
- The intervention successfully modulated gut microbial dysbiosis linked to D-galactose-induced aging.
DOI: 10.1039/d6fo02531e